Patent ID: 11872224
Assignee: TAIGEN BIOTECHNOLOGY CO., LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 4:
5. The amorphous solid dispersion according to claim 4, wherein the compound is [1-((11S)-7,8-difluoro(6H,11H-dibenzo[c,f]thiepin-11-yl))-4,6-dioxospiro[1,2,3,9-tetrahydropyridino[1,2-e[pyridazine-3,1′-cyclopropane[-5-yloxy[methyl methoxyformate or 1′ -((11S)-7,8-difluoro-6, 11-dihydrodibenzo [b,e]thiepin- 11-yl)- 1′ ,2′ -dihydro-5′-hydroxy-spiro[cyclopropane-1,3′-(3H)pyrido[1,2-b[pyridazine-4′,6′-dione.